- United States
- /
- Medical Equipment
- /
- NasdaqGS:ATEC
Alphatec Holdings (NASDAQ:ATEC) Is Making Moderate Use Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. As with many other companies Alphatec Holdings, Inc. (NASDAQ:ATEC) makes use of debt. But should shareholders be worried about its use of debt?
Why Does Debt Bring Risk?
Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. When we examine debt levels, we first consider both cash and debt levels, together.
Check out our latest analysis for Alphatec Holdings
What Is Alphatec Holdings's Debt?
As you can see below, at the end of September 2022, Alphatec Holdings had US$361.9m of debt, up from US$327.1m a year ago. Click the image for more detail. However, it also had US$106.1m in cash, and so its net debt is US$255.8m.
How Healthy Is Alphatec Holdings' Balance Sheet?
Zooming in on the latest balance sheet data, we can see that Alphatec Holdings had liabilities of US$125.5m due within 12 months and liabilities of US$389.8m due beyond that. Offsetting this, it had US$106.1m in cash and US$50.7m in receivables that were due within 12 months. So it has liabilities totalling US$358.4m more than its cash and near-term receivables, combined.
This deficit isn't so bad because Alphatec Holdings is worth US$1.47b, and thus could probably raise enough capital to shore up its balance sheet, if the need arose. However, it is still worthwhile taking a close look at its ability to pay off debt. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately the future profitability of the business will decide if Alphatec Holdings can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.
Over 12 months, Alphatec Holdings reported revenue of US$319m, which is a gain of 50%, although it did not report any earnings before interest and tax. With any luck the company will be able to grow its way to profitability.
Caveat Emptor
Despite the top line growth, Alphatec Holdings still had an earnings before interest and tax (EBIT) loss over the last year. Indeed, it lost US$126m at the EBIT level. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. Another cause for caution is that is bled US$145m in negative free cash flow over the last twelve months. So in short it's a really risky stock. When analysing debt levels, the balance sheet is the obvious place to start. However, not all investment risk resides within the balance sheet - far from it. To that end, you should be aware of the 4 warning signs we've spotted with Alphatec Holdings .
If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:ATEC
Alphatec Holdings
A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
Undervalued with reasonable growth potential.